Fibroblast Growth Factor 23 is a Potential Prognostic Biomarker in Uterine Sarcoma

CONCLUSION: FGF23 was highly expressed in US and was promising as a novel potential biomarker for the diagnosis and prognosis of US.PMID:38613349 | PMC:PMC11015760 | DOI:10.1177/15330338241245924

Source: Technology in Cancer Research and Treatment - April 13, 2024 Category: Cancer & Oncology Authors: Ling Yang Ying Cai Yunjia Wang Yue Huang Chi Zhang Hu Ma Jian-Guo Zhou Source Type: research